NFA
AMAG

Nationwide Fund Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Nationwide Fund Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,978
Closed -$941K – 2631
2017
Q3 		$941K Sell
50,978
-1,646
-3% -$30.7K ﹤0.01% 1831
2017
Q2 		$968K Buy
52,624
+5,800
+12% +$115K ﹤0.01% 1793
2017
Q1 		$1.06M Sell
46,824
-5,903
-11% -$141K ﹤0.01% 1718
2016
Q4 		$1.83M Sell
52,727
-2,535
-5% -$75.7K 0.01% 1441
2016
Q3 		$1.35M Sell
55,262
-3,500
-6% -$87.5K 0.01% 1601
2016
Q2 		$1.41M Buy
58,762
+36,367
+162% +$834K 0.01% 1533
2016
Q1 		$524K Buy
22,395
+2,070
+10% +$49.1K ﹤0.01% 2072
2015
Q4 		$614K Sell
20,325
-176,193
-90% -$5.69M ﹤0.01% 2003
2015
Q3 		$7.81M Buy
196,518
+82,000
+72% +$5.09M 0.04% 653
2015
Q2 		$7.91M Sell
114,518
-26,969
-19% -$1.7M 0.03% 710
2015
Q1 		$7.73M Buy
141,487
+54,260
+62% +$2.59M 0.03% 747
2014
Q4 		$3.72M Buy
87,227
+68,477
+365% +$2.47M 0.02% 1094
2014
Q3 		$598K Buy
18,750
+1,683
+10% +$35.9K ﹤0.01% 2103
2014
Q2 		$354K Buy
17,067
+407
+2% +$7.52K ﹤0.01% 2458
2014
Q1 		$322K Hold
16,660
– – ﹤0.01% 2269
2013
Q4 		$404K Sell
16,660
-491
-3% -$11.5K ﹤0.01% 2337
2013
Q3 		$368K Buy
17,151
+848
+5% +$20K ﹤0.01% 2370
2013
Q2 		$363K Buy
+16,303
New +$359K ﹤0.01% 2184

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nationwide Fund Advisors's AMAG Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2017, closing a stake of 50,978 shares — an estimated $941K sold.

Nationwide Fund Advisors first reported a position in AMAG in Q2 2013 and held it in 18 quarters. The position peaked at $7.91M in Q2 2015. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining AMAG Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 50,978 AMAG Pharmaceuticals shares in Q4 2017, an estimated $941K.
  • Nationwide Fund Advisors first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's AMAG Pharmaceuticals position peaked at $7.91M in Q2 2015.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.